drugset / Trial / NCT00751153
Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
NaSingle-groupOpen-labelTreatment
Summary
Subjects with HIV who have viral suppression on current regimen but also have side effects/intolerance will change their current regimen to a combination of Raltegravir and Atazanavir and be monitored for viral and immunological response and quality of life.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-10
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atazanavir | Other / unclassified | 400 mg | — |
| Subject | Raltegravir | Other / unclassified | 400 mg | — |